$MRK Phase 2 Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)…NCT02564380. Estimated Primary Completion Date -  05/2020